Background Although continuous positive airway pressure (CPAP) has become the first line
of therapy for obstructive sleep apnea (OSA), it remains controversial whether non-sleepy …

Objective Studies suggest that continuous positive airway pressure (CPAP) therapy may
decrease blood pressure for patients with obstructive sleep apnoea (OSA). However, these …

Context Continuous positive airway pressure (CPAP) is the first-line treatment for patients
with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with …

Patients with untreated obstructive sleep apnea hypopnea (OSAH) are predisposed to
developing hypertension, and therapy with continuous positive airway pressure (CPAP) may …

Background: Obstructive sleep apnoea syndrome (OSAS) affects an estimated 2–4% of the
middle aged population. Meta-analyses of randomised controlled trials have shown that the …

Rationale: Continuous positive airway pressure (CPAP) is the current treatment for patients
with symptomatic obstructive sleep apnea (OSA). Its use for all subjects with sleep …

Purpose Continuous positive airway pressure (CPAP) therapy may decrease the risk of
mortality and cardiovascular events in patients with obstructive sleep apnea. However, these …

Rationale: Twenty-eight percent of people with mild to moderate obstructive sleep apnea
experience daytime sleepiness, which interferes with daily functioning. It remains unclear …

Study Objectives: We sought to perform a patient-level meta-analysis using the individual
patient data of the trials identified in our previous study-level meta-analysis investigating the …

Background: Obstructive sleep apnea (OSA) may lead to the development of hypertension
and therapy with continuous positive airway pressure (CPAP) can promote reduction in …